202 related articles for article (PubMed ID: 27781380)
1. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
[TBL] [Abstract][Full Text] [Related]
2. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
[TBL] [Abstract][Full Text] [Related]
3. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
7. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
[TBL] [Abstract][Full Text] [Related]
8. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.
Stevens SJ; Blank BS; Smits PH; Meenhorst PL; Middeldorp JM
AIDS; 2002 May; 16(7):993-1001. PubMed ID: 11953465
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
10. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
[TBL] [Abstract][Full Text] [Related]
11. Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.
Slyker JA; Casper C; Tapia K; Richardson B; Bunts L; Huang ML; Maleche-Obimbo E; Nduati R; John-Stewart G
J Infect Dis; 2013 Jun; 207(12):1798-806. PubMed ID: 23493724
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients.
Hijlkema SH; van Kampen JJA; Voermans JJC; den Oudsten MYE; Doorduijn J; van Lugtenburg PJ; van de Vijver DAMC; van der Ende ME
Infect Dis (Lond); 2018; 50(11-12):847-852. PubMed ID: 30317893
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
[TBL] [Abstract][Full Text] [Related]
15. EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria.
Habeeb R; Al Hafar L; Monem F
J Infect Dev Ctries; 2021 Dec; 15(12):1917-1922. PubMed ID: 35044951
[TBL] [Abstract][Full Text] [Related]
16. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
17. Short Communication: CD4 Count and HIV RNA Trends for HIV-Associated Lymphoproliferative Disorders in Malawi.
Kaimila B; van der Gronde T; Kasonkanji E; Fox P; Chikasema M; Tewete B; Gopal S
AIDS Res Hum Retroviruses; 2017 Oct; 33(10):1045-1047. PubMed ID: 28548539
[TBL] [Abstract][Full Text] [Related]
18. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P
Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
